Archive for 'Partnering'

Medical device company Sorin Group acquires Neurotech (LLN, Belgium), a development-stage company focused on neurostimulation

Medical device company Sorin Group acquires Neurotech (LLN, Belgium), a development-stage company focused on neurostimulation

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, recently announced the acquisition of Neurotech SA, a developer of neurostimulation devices out of Belgium. Created as a spin-off in [...]

Centexbel weaves a tighter cross-border mesh in the medical textile sector thanks to DIMETEX

Centexbel weaves a tighter cross-border mesh in the medical textile sector thanks to DIMETEX

Between textiles and medicine a finer mesh is being woven creating a tighter cross-border net for both sectors. Orthopedic braces, bandages, implants and other medical textiles are at the center of one of the most innovative [...]

Nanomedicine expert LDRI (UCL, Belgium) partners in European program to find oral alternative for Diabetics.

Nanomedicine expert LDRI (UCL, Belgium) partners in European program to find oral alternative for Diabetics.

The Louvain Drug Research Institute (LDRI) of the Catholic University of Louvain (UCL), expert in nanomedecine, is participating in a new European program in a fight against diabetes. The aim is to develop new methods of [...]

International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.

International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.

Active in Europe, the United States and Asia, a company respectfully established in the fields of biostatistics, data management and central randomization, IDDI has created a new monitoring system responding to the importance and high recommendation of [...]

UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis

UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis

First Patient Randomized Marks Start of Phase 3 Program to Evaluate Safety and Efficacy of CDP7851/AMG 785 in Women With Postmenopausal Osteoporosis Brussels, Belgium & Thousand Oaks, Calif., (April 4, 2012) UCB (Euronext Brussels: UCB) and [...]